Published: 3 March 2016

Publications

Quarterly Summary of Recent Safety Communications

This article is more than five years old. Some content may no longer be current.

Prescriber Update 37(1): 14
March 2016

The early warning system provides current and historical information on safety concerns for medicines and medical devices. These warnings are intended to help consumers and healthcare professionals make informed decisions about their use of medicines and medical devices.

More information about the early warning system can be found on the Medsafe website (www.medsafe.govt.nz/safety/EWS/EWS.asp).

Dear Healthcare Professional (DHCP) Letters are intended to inform healthcare professionals about important new or updated safety information regarding a medicine. Dear Healthcare Professional Letters are prepared by the medicine sponsor and are published on the Medsafe website with the sponsor’s agreement.

Consumer Information Leaflets provide information about medicines and medical devices or medical conditions to consumers.

Date	Communication	Title
1 December 2015	DHCP Letter	Tarceva: Indication restricted to EGFR-activating mutations only (PDF 91 KB, 2 pages)
8 December 2015	DHCP Letter	Cellcept: New restrictions on use due to teratogenic risk (PDF 100 KB, 3 pages)
December 2015	Consumer Information	Severe Allergic Reactions (Anaphylaxis) to Medicines (PDF 231 KB, 1 page) Ko Nga Tauhohengã Mate Pãwera (Anaphylaxis) ki Ngã Rongoã (PDF 361 KB, 1 page)
11 January 2016	Consumer Information	How to safely give medicines to children (PDF 217 KB, 1 page)
11 January 2016	Consumer Information	Medicines and breastfeeding (PDF 227 KB, 1 page)
11 January 2016	Consumer Information	Serotonin Syndrome (PDF 646 KB, 2 pages)

If you would like to receive Medsafe's early warning communications you can subscribe at www.medsafe.govt.nz/profs/subscribe.asp